These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23996477)

  • 1. Quantitative assessment of the contribution of sodium-dependent taurocholate co-transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin.
    Bi YA; Qiu X; Rotter CJ; Kimoto E; Piotrowski M; Varma MV; Ei-Kattan AF; Lai Y
    Biopharm Drug Dispos; 2013 Nov; 34(8):452-61. PubMed ID: 23996477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP).
    Greupink R; Dillen L; Monshouwer M; Huisman MT; Russel FG
    Eur J Pharm Sci; 2011 Nov; 44(4):487-96. PubMed ID: 21945488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
    Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
    Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.
    Choi MK; Shin HJ; Choi YL; Deng JW; Shin JG; Song IS
    Xenobiotica; 2011 Jan; 41(1):24-34. PubMed ID: 20946088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling.
    Mitra P; Weinheimer S; Michalewicz M; Taub ME
    Drug Metab Dispos; 2018 Jul; 46(7):953-963. PubMed ID: 29666154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
    Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
    Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes.
    Szabó M; Veres Z; Bátai-Konczos A; Kékesi O; Kis E; Szabó K; Jemnitz K
    Toxicol In Vitro; 2014 Sep; 28(6):1136-43. PubMed ID: 24909372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity.
    Leslie EM; Watkins PB; Kim RB; Brouwer KL
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1170-8. PubMed ID: 17374746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.
    Wu ZT; Yao D; Ji SY; Ni X; Gao YM; Hui LJ; Pan GY
    Cell Physiol Biochem; 2016; 38(5):1815-30. PubMed ID: 27160211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
    Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
    Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism.
    Sheng J; Tian X; Xu G; Wu Z; Chen C; Wang L; Pan L; Huang C; Pan G
    Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.
    Ménochet K; Kenworthy KE; Houston JB; Galetin A
    Drug Metab Dispos; 2012 Sep; 40(9):1744-56. PubMed ID: 22665271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase.
    Fujino H; Saito T; Ogawa S; Kojima J
    J Pharm Pharmacol; 2005 Oct; 57(10):1305-11. PubMed ID: 16259759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate.
    Zhang Y; Panfen E; Fancher M; Sinz M; Marathe P; Shen H
    Mol Pharm; 2019 Jun; 16(6):2342-2353. PubMed ID: 31039308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations.
    Pan W; Song IS; Shin HJ; Kim MH; Choi YL; Lim SJ; Kim WY; Lee SS; Shin JG
    Xenobiotica; 2011 Jun; 41(6):501-10. PubMed ID: 21341987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes.
    Kouzuki H; Suzuki H; Ito K; Ohashi R; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1043-50. PubMed ID: 9694967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
    Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
    Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans.
    Liao M; Zhu Q; Zhu A; Gemski C; Ma B; Guan E; Li AP; Xiao G; Xia CQ
    Xenobiotica; 2019 Jul; 49(7):852-862. PubMed ID: 30132394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.